YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Uncovering Nesfatin-1 and Irisin Hormones in Schizophrenia and Psychosis Patients: a Comparative Investigation

dc.authorscopusid 59280101000
dc.authorscopusid 56318101800
dc.authorscopusid 55886751100
dc.contributor.author Dinçer, E.
dc.contributor.author Algul, S.
dc.contributor.author Ozcelik, O.
dc.date.accessioned 2025-05-10T16:55:06Z
dc.date.available 2025-05-10T16:55:06Z
dc.date.issued 2024
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Dinçer E., Van Yuzuncu Yil University, Faculty of Medicine, Department of Physiology, Van, 65100, Turkey; Algul S., Van Yuzuncu Yil University, Faculty of Medicine, Department of Physiology, Van, 65100, Turkey; Ozcelik O., Kastamonu University, Faculty of Medicine, Department of Physiology, Kastamonu, 37200, Turkey en_US
dc.description.abstract Objective: This study aims to elucidate the potential roles of the hormones nesfatin-1 and irisin in the pathophysiology of schizophrenia and psychosis. Methods: The study involved 80 participants, divided into three groups: schizophrenia (n=30), psychosis (n=20), and controls (n=30). Blood samples were collected from these participants, and the levels of irisin and nesfatin-1 were measured using the ELISA method. Results: The findings revealed that nesfatin-1 levels in schizophrenia patients were significantly higher compared to those in psychosis patients and controls. Additionally, nesfatin-1 levels in psychosis patients were significantly higher than in controls. In contrast, irisin levels were significantly lower in schizophrenia patients compared to both psychosis patients and controls. Discussion: These results suggest that nesfatin-1 and irisin may have important implications for understanding and treating schizophrenia and psychosis. Further research is needed to explore the roles of these hormones in the etiology, diagnosis, and treatment of these conditions. © 2024 en_US
dc.identifier.doi 10.1016/j.bionps.2024.100112
dc.identifier.issn 2666-1446
dc.identifier.scopus 2-s2.0-85209106472
dc.identifier.scopusquality Q3
dc.identifier.uri https://doi.org/10.1016/j.bionps.2024.100112
dc.identifier.uri https://hdl.handle.net/20.500.14720/3379
dc.identifier.volume 11 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Elsevier B.V. en_US
dc.relation.ispartof Biomarkers in Neuropsychiatry en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Irisin en_US
dc.subject Nesfatin-1 en_US
dc.subject Psychiatric Disorders en_US
dc.subject Psychosis en_US
dc.subject Schizophrenia en_US
dc.title Uncovering Nesfatin-1 and Irisin Hormones in Schizophrenia and Psychosis Patients: a Comparative Investigation en_US
dc.type Article en_US

Files